Contact
searchSearch
HMP Global

Conference Coverage

alopecia areata
Conference Coverage
JAK Inhibitors in Alopecia Areata: Long-Term Success, Individualized Strategy, and the Emerging Role of Eyebrow Outcomes
11/26/2025
Jessica Garlewicz
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data review, the presenters emphasized the need to think beyond the scalp, personalize treatment duration and dosing, and recognize the growing significance of eyebrow regrowth as a marker of patient satisfaction.
Through patient cases and data...
11/26/2025
The Dermatologist
atopic dermatitis
Conference Coverage
Clarifying the Role of IL-13 Inhibitors in Atopic Dermatitis: Clinical Profiles, Comparisons, and Real-World Application
11/26/2025
Jessica Garlewicz
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized mechanism-driven selection, real-world application, and a comparison of pivotal efficacy data for the 3 IL-13–related biologics currently available: dupilumab, lebrikizumab, and tralokinumab.
The session emphasized...
11/26/2025
The Dermatologist
Linda F. Stein Gold, MD
Conference Coverage
Charting a Path to Higher Treatment Targets With JAK Inhibition in Atopic Dermatitis
11/01/2025
Jessica Garlewicz
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating therapeutic expectations in AD care, analyzing data on existing JAK inhibitors, and encouraging dermatologists to challenge treatment inertia.
The session focused on elevating...
11/01/2025
The Dermatologist
Natasha Atanaskova-Mesinkovska, MD, PhD
Conference Coverage
JAK Inhibitors for Alopecia Areata: Clinical Insights and Emerging Strategies
10/28/2025
Jessica Garlewicz
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha Atanaskova-Mesinkovska, MD, PhD, presented a candid and case-based review of current treatment strategies for alopecia areata.
At Fall Clinical 2025, Natasha...
10/28/2025
The Dermatologist
acne
Conference Coverage
Optimizing Acne Management With Durable Topical and Oral Therapies
10/28/2025
Jessica Garlewicz
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025...
10/28/2025
The Dermatologist
April W. Armstrong, MD
Conference Coverage
Rethinking the Role of Orals: Where TYK2 Inhibitors Fit in Psoriasis Management
10/27/2025
Jessica Garlewicz
The discussion centered on patient preferences, mechanism-driven selectivity, and a growing oral therapy pipeline that may shift long-standing practice paradigms.
The discussion centered on patient preferences, mechanism-driven selectivity, and a growing oral therapy pipeline that may shift long-standing practice paradigms.
The discussion centered on...
10/27/2025
The Dermatologist
Mittal Patel-Cohen
Conference Coverage
Hidradenitis Suppurativa: Phenotypes, Pitfalls, and Expanding Treatments
10/26/2025
Riya Gandhi, MA
Dr Patel-Cohen laid out diagnostic pearls, comorbidity considerations, and an expansive update on both conventional and emerging therapies of hidradenitis suppurativa.
Dr Patel-Cohen laid out diagnostic pearls, comorbidity considerations, and an expansive update on both conventional and emerging therapies of hidradenitis suppurativa.
Dr Patel-Cohen laid out...
10/26/2025
The Dermatologist
Brett King
Conference Coverage
Challenges and Treatments in Alopecia Areata
10/26/2025
Riya Gandhi, MA
At Dermatology Week 2025, Brett King, MD, PhD, presented an energizing overview of how far alopecia areata (AA) care has come, and where it is headed.
At Dermatology Week 2025, Brett King, MD, PhD, presented an energizing overview of how far alopecia areata (AA) care has come, and where it is headed.
At Dermatology Week 2025, Brett...
10/26/2025
The Dermatologist
Elizabeth (Lisa) A. Swanson, MD
Conference Coverage
Oral Therapies in Focus: Where Pills Fit in a Biologic-Dominated Psoriasis Landscape
10/24/2025
Jessica Garlewicz
This panel addressed emerging oral IL-23 inhibitors, the durability of current biologics, and patient preferences, framing the discussion around evolving treatment goals like on-treatment remission and real-world clinical needs.
This panel addressed emerging oral IL-23 inhibitors, the durability of current biologics, and patient preferences, framing the discussion around evolving treatment goals like on-treatment remission and real-world clinical needs.
This panel addressed emerging...
10/24/2025
The Dermatologist
psoriasis
Conference Coverage
Integrating GLP-1 Receptor Agonists in Psoriatic Disease: A Dual-Target Approach to Inflammation and Obesity
10/24/2025
Jessica Garlewicz
The discussion centered on the dual role of these agents in reducing systemic inflammation and promoting weight loss—2 factors strongly linked to psoriasis pathophysiology and therapeutic response.
The discussion centered on the dual role of these agents in reducing systemic inflammation and promoting weight loss—2 factors strongly linked to psoriasis pathophysiology and therapeutic response.
The discussion centered on the...
10/24/2025
The Dermatologist

Popular Articles

psoriatic arthritis
News
Assessing Areal Bone Mineral Density in Psoriatic Arthritis and Psoriasis
02/15/2024
Jessica Garlewicz
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone mineral density and bone quality in patients with psoriasis alone or with psoriatic arthritis compared to matched control subjects.
Researchers aimed to assess bone...
02/15/2024
The Dermatologist
Dr David Carr
Videos
Advancing a Mohs Surgery Leadership Program
04/03/2024
David R. Carr, MD, MPH, FACMS
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how these initiatives contribute to the advancement of Mohs surgery...
In this interview, Dr Carr...
04/03/2024
The Dermatologist
Joel M. Gelfand, MD, MSCE
Conference Coverage
Hot Topics in Dermatology
05/08/2024
Jessica Garlewicz
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
The session aimed to delve into...
05/08/2024
The Dermatologist
Atopic dermatitis
News
Arcutis Presents Long-Term Data on Roflumilast Cream for Atopic Dermatitis
06/11/2024
Riya Gandhi, MA
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia...
06/11/2024
The Dermatologist
psoriatic arthritis
News
Vaccination Recommendations for Patients Receiving Antipsoriatic Systemic Therapies
07/26/2024
Jessica Garlewicz
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate...
07/26/2024
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use